Insomnia: Mechanisms, Hyperarousal, Sleep Hygiene Limits, and Evidence-Based Treatment Strategies for Adults

Insomnia is a persistent difficulty with initiating sleep, maintaining sleep, or obtaining restorative sleep, occurring despite adequate opportunity and resulting in daytime impairment. Clinically, it is not merely a short-term bad night; it is defined by duration (commonly at least 3 nights per week for 3 months) and by the effects on cognition, mood, energy, and overall function. Insomnia may be primary or comorbid with medical conditions (e.g., chronic pain, asthma, reflux), psychiatric disorders (notably depression and anxiety), neurologic disease, or substance-related factors. Understanding why people struggle requires focusing on three interacting domains: predisposing vulnerabilities, precipitating triggers, and perpetuating mechanisms.

The most common underlying driver of chronic insomnia is physiologic and cognitive hyperarousal. Hyperarousal reflects an overactive stress response system in which sleep is less likely to occur and more likely to be fragmented once it begins. Neurobiologically, insomnia has been linked to dysregulation across arousal pathways, including altered function of neurotransmitter systems that normally promote sleep stability, such as GABAergic inhibition and circadian regulatory signaling. Many patients show heightened sympathetic activation (e.g., increased stress hormones, elevated autonomic tone) and impaired sleep-dependent downregulation. Instead of smoothly transitioning into sleep, the brain remains “on guard,” leading to prolonged sleep latency and frequent awakenings.

A second perpetuating mechanism is behavioral conditioning. When individuals repeatedly associate the bed with wakefulness—lying awake for long periods, checking the clock, scrolling on a phone, or attempting to “force sleep”—the conditioned cue (bed/bedroom) elicits arousal rather than sleep. Over time, the individual may compensate with increased time in bed, naps, or irregular schedules. These behaviors further fragment sleep pressure (the homeostatic drive for sleep) and destabilize circadian timing. This explains why sleep hygiene alone often fails: it can reduce risk factors but does not reliably extinguish the learned arousal response.

Cognitive factors intensify insomnia through worry, threat appraisal, and performance pressure. Common cognitive patterns include “sleep effort” (trying hard to sleep), catastrophic interpretations of poor sleep (“I’ll be unable to function tomorrow”), and selective attention to bodily sensations (monitoring wakefulness). Such rumination and monitoring increase cognitive arousal, which delays sleep onset and increases the likelihood of waking. This is often conceptualized through models such as the cognitive-behavioral framework emphasizing maladaptive beliefs (“sleep must come quickly”) and the perpetuating cycle of arousal.

Circadian misalignment can also be a key contributor, especially in people with delayed sleep phase, shift-work schedules, or inconsistent wake times. When circadian signals for sleep propensity do not align with behavioral timing, sleep becomes difficult to initiate. Bright light exposure at night, late caffeine consumption, or irregular sleep-wake schedules can shift circadian phase and reduce the probability of sleep onset. In these cases, the insomnia is not caused solely by “poor habits” but by disrupted timing signals that require structured circadian interventions.

The next step in evaluation is a thorough assessment of insomnia phenotype and comorbidities: medical conditions (e.g., pain, restless legs syndrome characterized by urge to move with uncomfortable sensations), sleep-disordered breathing (snoring, witnessed apneas, nonrestorative sleep), medication effects (stimulants, steroids, some antidepressants), substance use (nicotine, alcohol), and mood/anxiety disorders. Differentiating these entities matters because treatment differs. For example, restless legs syndrome responds to iron repletion when ferritin is low and to dopaminergic or alpha-2-delta ligands in selected cases; sleep apnea requires airway management rather than sedative-only approaches.

Evidence-based treatment for chronic insomnia primarily centers on Cognitive Behavioral Therapy for Insomnia (CBT-I). CBT-I targets the perpetuating mechanisms: stimulus control (use the bed only for sleep and sex; leave bed if unable to sleep), sleep restriction (temporarily reducing time in bed to increase sleep drive while monitoring safety and daytime functioning), cognitive restructuring (reducing catastrophic beliefs and sleep effort), and relaxation strategies. CBT-I improves sleep continuity, reduces insomnia severity, and demonstrates durable benefits compared with many pharmacologic options.

Medications may be used short-term or when CBT-I is unavailable. However, many hypnotics primarily suppress symptoms and can lead to tolerance, dependence, or next-day impairment, especially in older adults. Sedating antihistamines are also often discouraged due to anticholinergic burden and limited efficacy. Clinicians increasingly favor a combined approach where pharmacotherapy is adjunctive while CBT-I is implemented.

Addressing insomnia’s “main reason people struggle” therefore usually means recognizing hyperarousal and the perpetuating cycle—cognitive worry, conditioned arousal, and circadian disruption—rather than blaming willpower or insufficient sleep hygiene alone. Persistent insomnia is a treatable condition, and effective management depends on identifying the dominant maintaining mechanism for each individual.

Source: [Creator @Bis_ade_]